Concepedia
Statistics
Publications
10
Citations
817
H-Index
Active since
2003
Affiliations
Johns Hopkins University(Current)
Henan University
Soochow University
Protein Express (United States)
Shanghai Institute of Materia Medica
Dan Lu is an author at Johns Hopkins University specializing in oncology, signal transduction, and molecular biology.
Publications per year
2003–2022
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Douglas Burtrum, Zhenping Zhu, Dan Lu et al. · PubMed · 2003 · 349 citations
Medicine, Oncology, Pharmacology +15
Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member
Jennifer M. O'Toole, Karen E. Rabenau, Kerri Burns et al. · Cancer Research · 2006 · 120 citations
Medicine, Oncology, Pharmacology +13
Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2
Hua‐Quan Miao, Kun Hu, Xenia Jimenez et al. · Biochemical and Biophysical Research Communications · 2006 · 89 citations
Pharmacy, Molecular Pharmaceutics, Pharmaceutics +12
A recombinant, fully human, bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3
Xenia Jimenez, Dan Lu, Laura Brennan et al. · Molecular Cancer Therapeutics · 2005 · 64 citations
Pharmacy, Cancer Biology, Oncology +17
Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody
Yiwen Li, Hongli Li, Mei-Nai Wang et al. · Blood · 2004 · 53 citations · Full text
Medicine, Cancer Biology, Oncology +5
1–5 of 10